Company Filing History:
1 out of 34 
1 out of 3,685 
Years Active: 2006
Title: Thomas Anders Wilson Ericsson: Innovator in Thyroid Receptor Ligands
Introduction
Thomas Anders Wilson Ericsson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with thyroid receptors. His work has implications for treating metabolic dysfunctions and related disorders.
Latest Patents
Ericsson holds a patent for "Benzamide derivatives as thyroid receptor ligands." This invention relates to novel compounds that serve as thyroid receptor ligands and outlines methods for preparing these compounds. Additionally, the patent describes a method for preventing, inhibiting, or treating diseases associated with metabolic dysfunction or dependent on the expression of a T3 regulated gene, wherein the described compounds are administered in therapeutically effective amounts. He has 1 patent to his name.
Career Highlights
Throughout his career, Thomas Ericsson has worked with prominent companies in the pharmaceutical industry. Notable among these are Karo Bio AB and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Ericsson has collaborated with esteemed colleagues, including Neeraj Garg and Mahmoud Rahimi Ghadim. These partnerships have fostered innovation and have been instrumental in his research endeavors.
Conclusion
Thomas Anders Wilson Ericsson is a distinguished inventor whose work on thyroid receptor ligands has the potential to impact the treatment of metabolic disorders. His contributions to the field of medicinal chemistry are noteworthy and reflect his commitment to advancing healthcare solutions.